High-throughput screening method of KRAS mutations at codons 12 and 13 in formalin-fixed paraffin-embedded tissue specimens of metastatic colorectal cancer

Japanese Journal of Cancer and Chemotherapy

Volumn 38, Issue 11, 2011, Pages 1825-1835

  Fukushima, Yoshiyuki ^a   Yanaka, Shoko ^a   Murakami, Kazumi ^a   Abe, Yukiko ^a   Koshizaka, Takuya ^a   Hara, Hirotaka ^a   Samejima, Chihiro ^a   Kishi, Yoshiro ^a   Kaneda, Makoto ^a   Yoshino, Takayuki ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Anti EGFR antibody; KRAS gene mutation; Luminex (xMAP) method

Indexed keywords

PARAFFIN;

ARTICLE; CANCER TISSUE; CODON; COLORECTAL CANCER; FLUORESCENCE ANALYSIS; GENE IDENTIFICATION; GENE MUTATION; HIGH THROUGHPUT SCREENING; METASTASIS; ONCOGENE K RAS; POLYMERASE CHAIN REACTION;

EID: 84856030898     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Khambata-Ford S, Garrett CR, Meropol NJ, et al: Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J Clin Oncol 25(22): 3230-3237, 2007. (Pubitemid 47325606)
2. Lièvre A, Bachet JB, Le Corre D, et al: KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 66(8): 3992-3995, 2006.
3. Di Fiore F, Blanchard F, Charbonnier F, et al: Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. Br J Cancer 96(8): 1166-1169, 2007. (Pubitemid 46625066)
4. Dahabreh IJ, Terasawa T, Castaldi PJ, et al: Systematic review: anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancer. Ann Intern Med 154(1): 37-49, 2011.
5. Gilbert MT, Haselkorn T, Bunce M, et al: The isolation of nucleic acids from fixed, paraffin-embedded tissueswhich methods are useful when ? PLoS One 2(6): e537, 2007.
6. Shi SR, Datar R, Liu C, et al: DNA extraction from archival formalin-fixed, paraffin-embedded tissues: heat-induced retrieval in alkaline solution. Histochem Cell Biol 122(3): 211-218, 2004. (Pubitemid 39371490)
7. Kellar KL and Iannone MA: Multiplexed microsphere-based flow cytometric assays. Exp Hematol 30(11): 1227-1237 2002 (Pubitemid 35287575)
8. Itoh Y, Mizuki N, Shimada T, et al: High-throughput DNA typing of HLA-A, -B, -C and -DRB1 loci by a PCR-SSOP-luminex method in the Japanese population. Immunogenetics 57(10): 717-729, 2005. (Pubitemid 41598618)
9. Sheridan C: EGFR inhibitors embrace KRAS. Nat Biotechnol 26(8): 839-840, 2008.
10. Andreyev HJ, Norman AR, Cunningham D, et al: Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study. Natl Cancer Inst 90(9): 675-684, 1998. (Pubitemid 28222141)
11. Whitehall V, Tran K, Umapathy A, et al: A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting. J Mol Diagn 11(6): 543-552, 2009.
12. Laosinchai-Wolf W, Ye F, Tran V, et al: Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens. J Clin Pathol 64(1): 30-36, 2011.